Historique
Auteur S. ELLIOTT
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat à votre sélection Affiner la recherche
J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : Périodique2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]
S. ELLIOTT ; J. EVANS | 2014
Dans Forensic Science International (Vol.243, October 2014) Article : PériodiqueFollowing the initial popularity of mephedrone (4-methylmethcathinone) there has been a stream of new "recreational drugs" entering the global market. The lack of clinical studies on the effects and toxicity of these drugs has made interpretatio[...]
S. ELLIOTT ; R. SEDEFOV ; M. EVANS-BROWN | 2018
Dans Drug Testing and Analysis (Vol.10, n°1, January 2018) Article : PériodiqueThe number of new psychoactive substances (NPS) has increased significantly, especially within the last 5 years. The EMCDDA conducts risks assessments of such substances, especially in relation to serious adverse events. Examination of the indiv[...]
E. DANENBERG ; L. A. SORGE ; W. WIENIAWSKI ; S. ELLIOTT ; L. AMATO ; W. K. SCHOLTEN | 2013
Dans Drug and Alcohol Dependence (Vol.131, n°3, August 2013) Article : PériodiqueBackground: The WHO Executive Board revised the guidance that governs the procedures for the WHO review of psychoactive substances for international drug control in 2010. To meet the standards defined in these guidelines, the current evaluation [...]
This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe), that was conducted by the Scientific Committee of the EMCDDA. Concer[...]
ENGLISH : Gamma-hydroxybutyric acid (GHB) and its precursor gamma-butyrolactone (GBL) are regularly implicated in instances of surreptitious drug administration, particularly in beverages (so-called "spiked drinks"). In order to assist in the [...]
J. M. CORKERY ; E. DURKIN ; S. ELLIOTT ; F. SCHIFANO ; A. H. GHODSE | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : Périodique5-MeO-DALT (N,N-diallyl-5-methoxytryptamine) is a psychoactive substance, sold primarily over the Internet as a 'research chemical' or 'plant food'. Although details for the synthesis of this tryptamine have been available since 2004, its use as[...]
